Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types-Reference-Cited by-同舟云学术

Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types

Published:2024-08-16 Issue: Volume: Page:
ISSN:2948-2933
Container-title:Journal of Imaging Informatics in Medicine
language:en
Short-container-title:J Digit Imaging. Inform. med.

Author:

Tian Chongxuan,Xi Yue,Ma Yuting,Chen Cai,Wu Cong,Ru Kun,Li Wei,Zhao Miaoqing

Funder

the National Natural Science Foundation of China

Shandong Provincial Key Research and Development Program

Shandong Provincial Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10278-024-01107-9.pdf

Reference34 articles.

1. HOANGXUAN K, BESSELL E, BROMBERG J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the europeanassociation for neuro - oncology[J]. Lancet Oncol, 2015, 16( 7) : 322 - 332.

2. Yao Lin, Jie Pingping, Liu Yong. The value of 3.0T magnetic resonance diffusion tensor imaging in the differential diagnosis of high-grade glioma and brain metastases [J]. Journal of Clinical Radiology, 2020, 39(1) : 22–25.

3. Suh CH, Kim HS, Jung SC, et al. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis[J]. J Magn Reson Imaging, 2019, 50: 560-572.

4. Du Enfu, Xu Lin, Zhou Xuanmin, et al.Discussion on the diagnostic value of plain CT and enhanced MRI in primary central nervous system lymphoma[J].Practical Hospital Clinical Journal, 2018, 15: 246–247.

5. Yang Zhicheng, Leng Shanshan, Duan Wenjuan. Clinical significance of MRI in the differential diagnosis of primary central nervous system lymphoma and multiple brain glioma[J]. Journal of Clinical and Experimental Medicine ,2019,18(5):548-551.